Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:



U.S. Corporate Transparency Act beneficial ownership reporting regulations take effect January 2024

The U.S. Congress enacted the Corporate Transparency Act (CTA) in 2020. The CTA for the first time created a federal obligation to report beneficial ownership information for most U.S....


TSA revises rail cybersecurity directives for passenger and freight railroads

In October 2023, the Transportation Security Administration (TSA) updated three of its cybersecurity directives regulating passenger and freight railroad carriers. The following...


Cross-border ESG - Green Leases across the Globe

With the ESG drumbeat growing louder for prospective investors, purchasers and occupiers we look at green leases from a global perspective.


MedTech 2023: Key takeaways from conversations on women’s health, antitrust, and AI

AdvaMed recently hosted its annual MedTech Conference in Anaheim, California, at which Hogan Lovells lawyers and regulatory specialists convened with business leaders, scientists,...

Insights and Analysis

SEC amends large shareholder reporting rules
Registered Content

On October 10, the SEC adopted long-awaited amendments to Regulation 13D-G under the Exchange Act, which requires beneficial owners of more than 5% of a class of voting equity securities...


Informed consent duties for IRBs, investigators, and sponsors detailed in FDA final guidance

Nine years after the draft version was published, the Food and Drug Administration (FDA) has finalized its guidance on informed consent for sponsors, institutions, IRBs, and investigators....


Biodiversity: incorporating nature and TNFD into your strategy

Just as the financial community is getting to grips with TCFD, TNFD has arrived. TNFD provides a framework for disclosure of nature-related financial information – the ways in...


FDA broadens scope on communication about unapproved uses to HCPs

The U.S. Food and Drug Administration (FDA) published new draft guidance on “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of...


Post-COVID, FDA still permits changes to non-invasive remote monitoring devices without 510(k)

The U.S. Food and Drug Administration (FDA) has revised its guidance on non-invasive remote monitoring devices used to support at-home patient monitoring, replacing its March 2020 guidance...

Loading data